Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
ABSTRACT Reactivation of Epstein-Barr virus (EBV) from latency into the lytic phase of its life cycle allows the virus to spread among cells and between hosts. Valproic acid (VPA) inhibits initiation of the lytic cycle in EBV-infected B lymphoma cells. While VPA blocks viral lytic gene expression, i...
Guardado en:
Autores principales: | Kelly L. Gorres, Derek Daigle, Sudharshan Mohanram, Grace E. McInerney, Danielle E. Lyons, George Miller |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cf69ace380fa4a8f868716425cabda6e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation
por: Yuchen Zhang, et al.
Publicado: (2020) -
Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
por: Nicholas Van Sciver, et al.
Publicado: (2021) -
Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
por: Daniela F Angelini, et al.
Publicado: (2013) -
Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.
por: Jianmin Zuo, et al.
Publicado: (2011) -
Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidine.
por: Sheng-Yen Huang, et al.
Publicado: (2013)